Too often, fertility is framed as an inherently high-cost benefit—one where coverage automatically leads to runaway utilization. In reality, the most expensive fertility claims rarely stem from coverage itself. They are far more likely to result from late engagement, unmanaged pathways, and the absence of early, clinically guided education.
For employers focused on cost control, the question isn’t whether to support fertility—but when and how that support begins.
The cost misconceptions that continue to shape decisions
Two assumptions still dominate fertility conversations:Misconception 1: “Covering fertility leads to uncontrolled spend.”
Misconception 2: “Greater access automatically means more claims.”
These assumptions overlook a critical reality: Fertility costs escalate most when individuals enter care late, without guidance, and after underlying risks have gone unaddressed. When fertility support begins only after diagnosis or treatment is already underway, employers are left managing utilization rather than influencing outcomes.
What the data shows
Research consistently points to early education and intervention as key drivers of better outcomes and more predictable spend.For example:
- Up to 50% of infertility cases involve male factors, yet male testing is often delayed or overlooked, prolonging time-to-pregnancy and increasing unnecessary interventions¹
- Individuals who receive preconception guidance and early clinical support are more likely to optimize health before treatment, reducing escalation to more invasive and costly options²
- Structured fertility pathways with clinical oversight are associated with shorter time-to-pregnancy and lower rates of avoidable utilization, compared to unmanaged, self-directed care³
When fertility support starts late, costs rise quickly. When it starts early, employers gain control.
Why preconception is the most overlooked cost lever
Traditional fertility benefits often activate after a diagnosis—or once treatment is already underway. But many of the most impactful interventions occur well before that point.Preconception support can include:
- Early identification of hormonal, lifestyle, or medical risk factors
- Male and female testing to avoid months of unnecessary delays and interventions
- Guidance on nutrition, stress, sleep, and cycle tracking that supports unassisted conception
What this looks like in practice:
Closing the preconception gap For employers looking to translate early education and preconception support into real outcomes, structure matters. WIN recently expanded its preconception program to address one of the most persistent gaps in fertility care: Support beginning before diagnosis or treatment, when intervention is most effective. Traditional fertility benefits often activate too late, once challenges are already identified or treatment is underway. WIN’s expanded preconception program closes that gap with a clinically guided, data-informed pathway designed to help individuals and partners optimize reproductive health earlier, improving outcomes while reducing unnecessary escalation.Key elements of the program include:
- 24/7 nurse advocacy supported by AI-driven insights, delivering personalized care plans through the WINFamily app and maintaining consistent clinical oversight
- Early partner testing, including semen analysis and hormone tracking, to identify male and female factors sooner and avoid months of unnecessary delay
- Automated data integration, incorporating test results, wearable data, and lifestyle inputs to support adaptive, real-time care plans
- Coordinated access to a national virtual network of reproductive specialists and wellbeing experts, ensuring timely intervention and continuity as members progress into fertility and maternity care
As Roger Shedlin, MD, CEO of WIN, notes:
“The fertility journey should start with preconception support. By combining early testing, wearable integration, and nurse-led clinical oversight, we’re improving outcomes for families while enabling employers to reduce high-cost claims and realize measurable ROI.”
How employers stay in control without limiting access
Employers that manage fertility spend effectively tend to focus less on limiting coverage and more on structuring care.Key elements include:
- Early, accessible education, so members understand options before escalating care
- Clinically guided pathways, not open-ended utilization
- Ongoing oversight, ensuring treatment decisions are appropriate and timely
From fertility coverage to fertility strategy
Fertility benefits don’t have to be unpredictable or cost-prohibitive. But they do require a shift in mindset—from reactive coverage to proactive strategy.Employers that invest in early education, preconception support, and structured clinical guidance are better positioned to:
- Reduce unnecessary escalation
- Improve outcomes for employees
- Stabilize fertility-related spend over time
Looking ahead
As National Infertility Awareness Week brings fertility conversations into sharper focus, one thing is clear: The employers who see the strongest outcomes are those who engage early—before cost and complexity take hold.To learn how WIN supports fertility through early education, preconception guidance, and clinically led care—and how this approach helps employers maintain cost control while supporting employees—book a demo.
- American Society for Reproductive Medicine (ASRM). Male Infertility: Overview and Evaluation.
- Centers for Disease Control and Prevention (CDC). Infertility FAQs and Treatment Pathways.
- ASRM Practice Committee. Optimizing Natural Fertility.
- Stanford et al. “Effects of Preconception Care on Fertility Outcomes.” Human Reproduction Update.
